Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 2068069Generated: October 30, 2026

1-Boc-4-(3-hydroxypropyl)piperazine → HCID 67019221, compound

https://huagongshe.com/reaction/2068069

Reaction equation

Participants

RoleNameHCIDCharge
Reactant1-Boc-4-(3-hydroxypropyl)piperazineHCID 16217800—
Reactant4-((4-Fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxyquinazolin-7-olHCID 135530832—
ProductHCID 67019221HCID 6701922170%

Reaction Steps

Using an analogous procedure to that described for the preparation of the starting material in Example 11, 1-tert-butoxycarbonyl-4-(3-hydroxypropyl)piperazine (432 mg, 1.77 mmol) was reacted with 4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-7-hydroxy-6-methoxyquinazoline (500 mg, 1.47 mmol), (prepared as described for the starting material in Example 7). The product was purified by column chromatography, eluting with 2%-5% methanol/methylene chloride to give tert-butyl 4-[3-(4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-6-methoxyquinazolin-7-yloxy)propyl]piperazine-1-carboxylate (582 mg, 70%).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08293902B2
Source datasetuspto-grants-2012_10
ORD IDord-a258b2b160e144f5b0adc80e97a7d9c3
Source noteuspto-grants-2012_10